US Patent Issued to ReacX Pharmaceuticals on Sept. 29 for "Implants for release of lipophilic or amphiphilic pharmaceutical substances" (California, Texas Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,275, issued on Sept. 29, was assigned to ReacX Pharmaceuticals Inc. (South San Francisco, Calif.).

"Implants for release of lipophilic or amphiphilic pharmaceutical substances" was invented by Rajesh A. Patel (Redwood City, Calif.), Sunil Sreedharan (South San Francisco, Calif.) and Benjamin Furman (San Antonio).

According to the abstract* released by the U.S. Patent & Trademark Office: "Implants are described which comprise lipophilic pharmaceutical substances. Excipients are used which provide appropriate and controllable/tunable release of the lipophilic drug from the matrix of the implant. The implants can be implanted into a patient for release of the pharmaceutical substan...